Clinical Trial: The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018)
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: A Phase IIa Randomized, Double-Blind, Parallel-Groups, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of MK0724 Intravenous Infusion on the Amelioration of Neurological Damage and
Brief Summary: The safety and efficacy of MK0724 will be assessed in patients with acute middle cerebral artery stroke using the Action Reach Arm Test (ARAT). This test allows measurement of a specific functional deficit and subsequent recovery correlating with the specific area of stroke in the brain.
Detailed Summary:
Sponsor: Merck Sharp & Dohme Corp.
Current Primary Outcome: Action Research Arm Test score [ Time Frame: At 90 days ]
Original Primary Outcome: Proprietary Information - Exploratory (Non-Confirmatory) Trial
Current Secondary Outcome: Scores on the Stroke Arm Strength question, modified Rankin, and Barthel Index. [ Time Frame: At 90 days ]
Original Secondary Outcome: Proprietary Information - Exploratory (Non-Confirmatory) Trial
Information By: Merck Sharp & Dohme Corp.
Dates:
Date Received: November 17, 2006
Date Started: July 2007
Date Completion:
Last Updated: July 21, 2015
Last Verified: July 2015